A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway

Local Institution - 001-116, Pittsburgh

Local Institution - 001-103, Baltimore

Local Institution - 001-104, Fairfax

Local Institution - 001-101, Nashville

Local Institution - 001-102, Nashville

Local Institution - 001-107, Houston

Local Institution - 001-105, Seattle

Local Institution - 001-108, New Haven

Local Institution - 001-119, Newark

Local Institution - 001-111, Orlando

Local Institution - 001-110, Rochester

Local Institution - 001-115, Hackensack

Local Institution - 001-106, Cincinnati

Local Institution - 001-109, Portland

Local Institution - 001-112, Dallas

Local Institution - 001-122, Fort Worth

Local Institution - 001-123, Tyler

Local Institution - 001-114, Rio Piedras